Neonatal sepsis in an intensive care unit and results of treatment.
Incidence and fatality of neonatal sepsis in intensive care units have been relatively high despite progress in the management of very ill neonates and combined treatment of sepsis with antibiotics. Between 1985 and 1989 944 children (632 premature babies and 312 term babies) were treated in the intensive care unit of the University Children's Hospital of Kiel. The incidence of sepsis was 5% (congenital sepsis 4%, sepsis acquired after birth 1%). Pneumonia occurred in 4% (congenital pneumonia in 2%, postnatal pneumonia in 2%). Early diagnosis and treatment with piperacillin plus cefotaxime reduced the mortality rate of sepsis to 2%. Sepsis never developed under treatment with piperacillin plus cefotaxime. Early recognition of neonatal sepsis by a good blood culture technique and beginning of treatment on first suspicion of sepsis with cefotaxime and piperacillin can improve the results especially in intensive care patients.
Simon
C
C
Universität-Kinderklinik Kiel, Germany.
Schröder
H
H
Beyer
C
C
Zerbst
T
T
D002439:Cefotaxime / Q000627:therapeutic use*; D004357:Drug Synergism; D006785:Hospitals, University; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy; D007363:Intensive Care Units, Neonatal; D008826:Microbial Sensitivity Tests; D010878:Piperacillin / Q000627:therapeutic use*; D011014:Pneumonia / Q000151:congenital / Q000175:diagnosis / Q000188:drug therapy*; D018805:Sepsis / Q000151:congenital / Q000175:diagnosis / Q000188:drug therapy*
D002439:Cefotaxime; D010878:Piperacillin